FLYNPOVI Trademark

Trademark Overview


On Tuesday, March 9, 2021, a trademark application was filed for FLYNPOVI with the United States Patent and Trademark Office. The USPTO has given the FLYNPOVI trademark a serial number of 90567941. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Cancer Prevention Pharmaceuticals, Inc.. The FLYNPOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of cancer, adenocarcinomas, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, duodenal diseases and disorders, colonic diseases and disorders, rectal diseases and disorders, urological disorders and diseases, gastrointestinal disorders and diseases, and hepatobiliary disorders and diseases; Pharmaceutical preparations to minimize the occurrence, progression, or recurrence of polyps and tumors; Pharmaceutical preparations for use in the treatment of Familial Adenomatous Polyposis and precancerous conditions; Pharmaceutical preparations for use in the prevention and treatment of cancer, precancerous conditions, tumors, polyps, adenomas, inflammation, ge...
flynpovi

General Information


Serial Number90567941
Word MarkFLYNPOVI
Filing DateTuesday, March 9, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment or prevention of cancer, adenocarcinomas, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, duodenal diseases and disorders, colonic diseases and disorders, rectal diseases and disorders, urological disorders and diseases, gastrointestinal disorders and diseases, and hepatobiliary disorders and diseases; Pharmaceutical preparations to minimize the occurrence, progression, or recurrence of polyps and tumors; Pharmaceutical preparations for use in the treatment of Familial Adenomatous Polyposis and precancerous conditions; Pharmaceutical preparations for use in the prevention and treatment of cancer, precancerous conditions, tumors, polyps, adenomas, inflammation, genetic diseases and disorders, oncological diseases and disorders, and duodenal disease
Pseudo MarkFLY N POVI; FLY AND POVI
Translation of Words in MarkThe word "FLYNPOVI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCancer Prevention Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTucson, AZ 85718

Party NameCancer Prevention Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85718

Trademark Events


Event DateEvent Description
Thursday, October 7, 2021NON-FINAL ACTION E-MAILED
Friday, March 12, 2021NEW APPLICATION ENTERED
Tuesday, June 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 1, 2021ASSIGNED TO EXAMINER
Thursday, October 7, 2021NON-FINAL ACTION WRITTEN
Thursday, October 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 19, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 19, 2022SOU EXTENSION 1 FILED
Monday, December 19, 2022SOU EXTENSION 1 GRANTED
Wednesday, December 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Thursday, May 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023SOU EXTENSION 2 FILED
Wednesday, April 26, 2023SOU EXTENSION 2 GRANTED
Friday, April 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024SOU EXTENSION 4 FILED
Tuesday, May 14, 2024SOU EXTENSION 4 GRANTED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 5 GRANTED
Friday, October 25, 2024SOU EXTENSION 5 FILED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED